David A. Siegel Royalty Pharma PLC Transaction History

Two Sigma Advisers, LP

$46.1 Billion
Q2 2025

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Royalty Pharma PLC stock. As of the latest transaction made, Two Sigma Advisers, LP holds 846,900 shares of RPRX stock, worth $30.4 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

846,900

Previous 2,903,900 70.84%

Holding current value

$30.4 Million

Previous $90.4 Million 66.25%

% of portfolio

0.07%

Previous 0.21%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$30.85 - $36.14 $63.5 Million - $74.3 Million	-2,057,000 Reduced 70.84%	846,900 $30.5 Million
Q1 2025 May 15, 2025	SELL	$25.75 - $33.86 $19.8 Million - $26 Million	-769,300 Reduced 20.94%	2,903,900 $90.4 Million
Q4 2024 Feb 14, 2025	BUY	$24.28 - $28.39 $15.5 Million - $18.2 Million	640,000 Added 21.1%	3,673,200 $93.7 Million
Q3 2024 Nov 14, 2024	BUY	$25.63 - $29.27 $24 Million - $27.4 Million	936,900 Added 44.69%	3,033,200 $85.8 Million
Q2 2024 Aug 14, 2024	BUY	$26.26 - $29.9 $15.1 Million - $17.2 Million	573,900 Added 37.7%	2,096,300 $55.3 Million
Q1 2024 May 15, 2024	SELL	$27.46 - $31.33 $13.1 Million - $15 Million	-478,700 Reduced 23.92%	1,522,400 $46.2 Million
Q4 2023 Feb 14, 2024	BUY	$26.21 - $29.22 $47,178 - $52,596	1,800 Added 0.09%	2,001,100 $56.2 Million
Q3 2023 Nov 14, 2023	BUY	$26.26 - $31.38 $27.6 Million - $33 Million	1,051,700 Added 110.99%	1,999,300 $54.3 Million
Q2 2023 Aug 14, 2023	BUY	$29.6 - $36.56 $18.7 Million - $23.1 Million	631,000 Added 199.31%	947,600 $29.1 Million
Q1 2023 May 15, 2023	SELL	$32.77 - $39.4 $8.88 Million - $10.7 Million	-271,100 Reduced 46.13%	316,600 $11.4 Million
Q4 2022 Feb 14, 2023	SELL	$39.17 - $44.04 $4.74 Million - $5.33 Million	-121,100 Reduced 17.09%	587,700 $23.2 Million
Q3 2022 Nov 14, 2022	SELL	$39.88 - $44.65 $1.72 Million - $1.93 Million	-43,200 Reduced 5.74%	708,800 $28.5 Million
Q2 2022 Aug 15, 2022	BUY	$37.53 - $44.22 $12.9 Million - $15.2 Million	344,600 Added 84.59%	752,000 $31.6 Million
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $5 Million - $5.66 Million	133,400 Added 48.69%	407,400 $15.9 Million
Q4 2021 Feb 14, 2022	BUY	$35.17 - $42.48 $6.22 Million - $7.51 Million	176,800 Added 181.89%	274,000 $10.9 Million
Q3 2021 Nov 15, 2021	BUY	$36.14 - $42.24 $3.51 Million - $4.11 Million	97,200 New	97,200 $3.51 Million

Others Institutions Holding RPRX

# of Institutions

496

Shares Held

306M

Call Options Held

1.99M

Put Options Held

384K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $15.7B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account